Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	0.24	-169.15	-169.56
Graham Fair Price	12.30	4.05	3.60
PEG	-4.02	-0.96	1.00
Price/Book	-32.85	2.26	3.36
Price/Cash Flow	63.68	-28.93	-79.64
Prices/Earnings	48.23	-30.21	-58.35
Price/Sales	-36.01	11.97	18.70
Price/FCF	63.68	-28.93	-79.64
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-11.00	0.17	0.19
Operating Margin	-7.40	-0.13	-0.12
ROA	-33.40	< 0.005	< 0.005
ROE	-0.01	-0.02	-29.71
ROIC	< 0.005	-0.01	-82.11
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.06	-96.60
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.02	-0.11	88.87
EPS QOQ	0.59	-0.32	-46.06
FCF QOQ	-0.88	-0.83	5.90
Revenue QOQ	0.03	0.04	43.55
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	16.99	16.47	-3.05
Days Sales Outstanding (DSO)	91.23	92.22	1.09
Inventory Turnover	5.30	5.46	3.14
Debt/Capitalization	0.36	0.36	0.91
Quick Ratio	1.74	1.63	-6.09
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.33	6.24	-1.40
Cash	3.41	2.88	-15.76
Capex	-0.37	-0.22	40.81
Free Cash Flow	-0.27	-0.49	-82.31
Revenue	1.14	1.18	3.47
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.94	1.86	-4.08
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.04	-12.49	-148.02
Naive Interpretation	Member

06 - Financial Health · Weak

Rating